Global hemostasis and tissue sealing agents market is expected to grow significantly and is projected to grow at a CAGR of 8.6% over the forecast period. Hemostats, adhesives and sealants are useful aides to modern surgical procedures. Topical hemostats are utilized intraoperatively first and postoperatively to a reduce extent. These products can be utilized to diffuse raw surface bleeding, bone bleeding, oozing venous type bleeds, and needle-opening bleeding. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Surgical procedures are medical interventions involving an incision with instruments usually performed in an operating theatre and normally involving various medical devices such as catheters and tubes. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S. Additionally, according to the NHS, surgery is the most important treatment offered by the NHS in secondary care within the UK.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7559
Furthermore, in 2015, NHS estimated that there were around 4.7 million surgical admissions in England, out of which 1.3 million procedures were for general surgery and around 1.2 million procedures were for trauma and orthopedics. These high surgical procedure numbers lead to rising need for hemostasis and tissue sealing agents which reduces the risk during surgical procedures. However, factors such as increasing advancement minimally invasive procedures, lack of reimbursement for these products is hampering the growth of the market.
Regional Analysis
Geographically, the Americas is anticipated to dominate the global hemostasis and tissue sealing agents market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S.
Europe is expected to hold the second largest position in the global hemostasis and tissue sealing agents market share. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the global hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Segmentation
The global hemostasis and tissue sealing agents market has been segmented into product, and end user.
By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.
Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others
Key Players
Some of the prominent players in the global hemostasis and tissue sealing agents market are Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc and others.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hemostasis-tissue-sealing-agents-market-7559
The global medical imaging workstations market is projected to grow at a CAGR of 8.5% over the forecast period.
The medical imaging workstations has become a base technology of modern medical diagnostics for the treatment of variety of acute and chronic diseases including cardiovascular diseases and cancer.
The usage of medical imaging/diagnostic workstations has reduced manual workflow and increased the accuracy and precision of diagnosis tremendously in recent years.
The factors influencing the growth of the market including growing government investment and funding’s for research in modernization of imaging services, favorable reimbursement policies and the on-going technological advancements in imaging systems to improve healthcare infrastructure is anticipated to boost the growth of the market over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7474Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth.
As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R) was Euro 33.1 billion (USD 35.2 billion) in the UK.
However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global medical imaging workstations market owing to the high clinical R budgets by both government as well as public and private organizations in diagnostic imaging modalities and rising adoption of advanced technologies.
The global medical imaging workstations market is projected to grow at a CAGR of 8.5% over the forecast period.
The medical imaging workstations has become a base technology of modern medical diagnostics for the treatment of variety of acute and chronic diseases including cardiovascular diseases and cancer.
The usage of medical imaging/diagnostic workstations has reduced manual workflow and increased the accuracy and precision of diagnosis tremendously in recent years.
The factors influencing the growth of the market including growing government investment and funding’s for research in modernization of imaging services, favorable reimbursement policies and the on-going technological advancements in imaging systems to improve healthcare infrastructure is anticipated to boost the growth of the market over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7474Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth.
As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R) was Euro 33.1 billion (USD 35.2 billion) in the UK.
However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global medical imaging workstations market owing to the high clinical R budgets by both government as well as public and private organizations in diagnostic imaging modalities and rising adoption of advanced technologies.
It stands among the top 20 global medical devices market.Market segment insights:The diagnostic imaging segment is considered to be the largest, owing to its ability to facilitate accurate detection of diseases.
Such participation from the public and private enterprises have resulted in the growth of the healthcare sector, thereby leading the medical devices market in India to prosper.The Indian government has allowed 100% foreign direct investment (FDI) in the medical devices industry.
Inflow of FDI is expected to spur research and development (R) activities and manufacturing innovations, which in turn can help in driving the growth of the medical devices market in India.
Excessive dependency on import of high-tech devices from the developed countries is hindering the growth of the domestic medical devices' manufacturers in India.Companies covered:Centenial Surgical Suture Ltd.Opto Circuits (India) Ltd.Poly Medicure Ltd.B.
Ltd.Philips India Ltd.Baxter International Inc.Becton, Dickinson and CompanyGE Healthcare Ltd.Medtronic, Inc.Siemens Healthineers, Inc.To Browse Full Research Report @: https://www.radiantinsights.com/research/medical-device-market-in-india-2018-2023Table of ContentsChapter 1: Executive summaryChapter 2: Socio-economic indicatorsChapter 3: Introduction3.1.
Medical devices market - definition3.2.
